Crossmark

Early applicability of retinopathy of prematurity score (ROPScore) and serum insulin growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity: a prospective cohort study

Crossref DOI link: https://doi.org/10.1186/s43054-024-00343-6

Published Online: 2025-01-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ali, Aliaa Adel

Gomaa, Nancy Abd El-Salam Ahmed

Kamil, Basma Samir

Awadein, Ahmed

Baz, Heba

Elmazzahy, Esraa Ahmed
License Information

Text and Data Mining valid from 2025-01-15

Version of Record valid from 2025-01-15
More Information

Article History

Received: 31 August 2024

Accepted: 30 December 2024

First Online: 15 January 2025

Declarations

:

: The study was approved by the Ethical Research Committee of Cairo University. The ethical approval number is MD-206-2022. Informed consents were obtained from the infants’ parents.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below